Rimsys
The first and only holistic Regulatory Information Management (RIM) software platform that consolidates all the functions of regulatory affairs, helping regulatory affairs professionals digitize, automate, and navigate the global regulatory landscape.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
* | N/A | $3.0m | Debt |
| Total Funding | 000k | ||
Related Content
Rimsys is a company focused on modernizing regulatory affairs for the medical technology (medtech) industry. It serves clients in the medtech sector, including manufacturers and regulatory professionals, by providing a comprehensive platform that centralizes and automates regulatory processes. The company operates in the global regulatory market, addressing the complexities and frequent changes in regulations such as the EU MDR IVDR rollout. Rimsys' business model revolves around a SaaS (Software as a Service) platform that integrates with existing clinical, product, and quality systems within an organization. This platform offers features like automated alerts, notifications, and digital maintenance of essential principles tables, ensuring that all stakeholders have access to consistent and up-to-date information. Rimsys makes money through subscription fees for its platform, which helps clients increase regulatory affairs (RA) productivity, manage complexity, and reduce compliance risks. The company also offers consulting services to assist with administrative tasks, making it a cost-effective solution for its clients.
Keywords: regulatory automation, medtech, compliance, SaaS, EU MDR IVDR, productivity, integration, alerts, digital maintenance, cost-effective.